Cargando…

Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations

BACKGROUND: Factors associated with care concordant with the American College of Rheumatology (ACR) recommendations for the use of disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis (RA) are unknown. METHODS: We identified a national cohort of biologic-naive patients with RA with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harrold, Leslie R., Reed, George W., Kremer, Joel M., Curtis, Jeffrey R., Solomon, Daniel H., Hochberg, Marc C., Kavanaugh, Arthur, Saunders, Katherine C., Shan, Ying, Spruill, Tanya M., Pappas, Dimitrios A., Greenberg, Jeffrey D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845312/ https://www.ncbi.nlm.nih.gov/pubmed/27118040 http://dx.doi.org/10.1186/s13075-016-0992-3

Ejemplares similares

Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis
por: Lillegraven, Siri, et al.
Publicado: (2019)

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
por: Harrold, Leslie R, et al.
Publicado: (2015)

The rheumatoid arthritis treat-to-target trial: a cluster randomized trial within the Corrona rheumatology network
por: Harrold, Leslie R, et al.
Publicado: (2014)

Malignancy validation in a United States registry of rheumatoid arthritis patients
por: Fisher, Mark C, et al.
Publicado: (2012)

Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry
por: Harrold, Leslie R., et al.
Publicado: (2016)

“Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients”
por: Pappas, Dimitrios A, et al.
Publicado: (2014)

Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population
por: Pappas, Dimitrios A., et al.
Publicado: (2015)

Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry
por: Harrold, Leslie R., et al.
Publicado: (2015)

TNFi Cycling Versus Changing Mechanism of Action in TNFi‐Experienced Patients: Result of the Corrona CERTAIN Comparative Effectiveness Study
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

Risk of Infection Associated With Subsequent Biologic Agent Use After Rituximab: Results From a National Rheumatoid Arthritis Patient Registry
por: Harrold, Leslie R., et al.
Publicado: (2016)

Hydroxychloroquine and the risk of respiratory infections among RA patients
por: Kremer, Joel M, et al.
Publicado: (2020)

Recommendations for the treatment of rheumatoid arthritis in Saudi Arabia: adolopment of the 2021 American College of Rheumatology guidelines
por: Omair, Mohammed A., et al.
Publicado: (2022)

One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry
por: Harrold, Leslie R., et al.
Publicado: (2018)

Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients with RA
por: Harrold, Leslie R., et al.
Publicado: (2021)

Cluster‐Randomized Trial of a Behavioral Intervention to Incorporate a Treat‐to‐Target Approach to Care of US Patients With Rheumatoid Arthritis
por: Harrold, Leslie R., et al.
Publicado: (2018)

Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis
por: Harrold, Leslie R., et al.
Publicado: (2017)

Korean College of Rheumatology: Forty Years of Excellence
por: Choe, Jung-Yoon, et al.
Publicado: (2022)

Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry
por: Harrold, Leslie R., et al.
Publicado: (2017)

Patient Governance in a Patient-Powered Research Network for Adult Rheumatologic Conditions
por: Nowell, W. Benjamin, et al.
Publicado: (2018)

Gender disparity in authorship of guidelines and recommendations in rheumatology
por: Adami, Giovanni, et al.
Publicado: (2020)

001 Egyptian consensus-based recommendations for the diagnosis and targeted management of Kawasaki disease. An initiative by the Egyptian College of Pediatric Rheumatology
por: El Miedany, Y, et al.
Publicado: (2022)

Delays in Initiation of Disease-Modifying Therapy in Rheumatoid Arthritis Patients: Data from a US-Based Registry
por: Pappas, Dimitrios A., et al.
Publicado: (2015)

Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis
por: Harrold, Leslie R., et al.
Publicado: (2018)

42 Egyptian evidence-based consensus recommendations for diagnosis and targeted management of juvenile dermatomyositis. An initiative by the Egyptian College of Pediatric Rheumatology
por: El Miedany, Y, et al.
Publicado: (2022)

Systematic Appraisal of the American College of Rheumatology Clinical Practice Guidelines
por: Duarte‐García, Alí, et al.
Publicado: (2019)

The Korean College of Rheumatology: 40 Years of Public Health Influence
por: Lee, Jisoo, et al.
Publicado: (2022)

Polish Medical Society of Radiology and Polish Society of Rheumatology Recommendations for Magnetic Resonance Imaging of Musculoskeletal Disorders in Rheumatology
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2015)

Conventional radiography in juvenile idiopathic arthritis: Joint recommendations from the French societies for rheumatology, radiology and paediatric rheumatology
por: Marteau, Pauline, et al.
Publicado: (2018)

Biosimilars in rheumatology: recommendations for regulation and use in Middle Eastern countries
por: El Zorkany, Bassel, et al.
Publicado: (2018)

Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis
por: Wei, James Cheng‐Chung, et al.
Publicado: (2019)

The outlook of rheumatological care in Africa: Current state, challenges, and recommendation
por: Nicholas, Aderinto, et al.
Publicado: (2022)

The Hong Kong Society of Rheumatology consensus recommendations for the management of gout
por: Yip, Ronald ML, et al.
Publicado: (2023)

Rheumatology
por: Blake, David R
Publicado: (1995)

A Model to Predict Future Biologic or Targeted Synthetic DMARD Switch at a Subsequent Clinic Visit in Rheumatoid Arthritis
por: Cappelli, Laura C., et al.
Publicado: (2023)

Translating research into practice—implementation recommendations for pediatric rheumatology; Proceedings of the childhood arthritis and rheumatology research alliance 2020 implementation science retreat
por: Yildirim-Toruner, Cagri, et al.
Publicado: (2022)

Unresolved Questions in Rheumatology: Motion for Debate: The Data Support Evidence-Based Management Recommendations for Cardiovascular Disease in Rheumatoid Arthritis
por: Solomon, Daniel H, et al.
Publicado: (2013)

Sex differences in gout characteristics: tailoring care for women and men
por: Harrold, Leslie R., et al.
Publicado: (2017)

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology
por: Buch, Maya H, et al.
Publicado: (2015)

EULAR recommendations for a core data set for pregnancy registries in rheumatology
por: Meissner, Yvette, et al.
Publicado: (2021)

Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability
por: Navarro-Millán, Iris, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jsn9q6m3denr840jk3laptal11